 manag hypertens cardiovascular risk blood pressur reduct hypertens patient surrog real therapeut goal risk consequ hypertens surrog conveni use import therapeut implic result treatment new antihypertens agent data clinic trial insight underli mechan overal success antihypertens therapi undeni frequenc atherosclerosi coronari event metabol disarray agent thiazid beta blocker electrolyt abnorm arrhythmia sudden death myocardi infarct left ventricular hypertrophi chief risk factor coronari event arrhythmia heart failur antihypertens agent progress renal injuri sensit agent obes hypertens evid atherogen abnorm common obes patient insulin resist nonobes patient sensit antihypertens agent